India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Engaging as Youth in Service, Production, Distribution, and Consumption #### Introduction In today's rapidly evolving world, the involvement of youth in key economic sectors is crucial for driving innovation and sustainability. This report explores various ways in which young people can engage in the service, production, distribution, and consumption sectors, contributing to their growth and evolution. The purpose is to provide a detailed overview of these sectors and actionable strategies for youth engagement. #### Service Sector The service sector encompasses activities that provide value to customers without producing physical goods. This sector is broad and includes areas such as healthcare, education, financial services, and technology services. It plays a critical role in modern economies, providing essential services that support daily life and business operations. ##### Examples Examples of services include healthcare services provided by hospitals and clinics, educational...